Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
31 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Amany Mohammed Abdel Moatamed 2024
32 Beta Endorphins, Interleukin 1 and Interleukin 38 in Covid Patients Associated with Neuropsychological Manifestations Department of Clinical Pathology Dr. Engy adel shafeek 2024
33 Factors affecting timing of hypothyroidism following radioactive iodine therapy (RAIT) for patients with Graves' disease: A 12-month observational study Department of Radiotherapy and Nuclear medicine ِAya AbdelBaset Ahmed 2024
34 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Shimaa Hassan Shabaan Hassan 2024
35 Family strategies formanaging childhood cancer: Using traditional and complementarymedicine in Southern Egypt Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2024
36 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2024
37 Prognostic Value of Vitamin D Receptor in Patients with Metastatic Colorectal Cancer Received Irinotecan-Based Systemic Treatment as a Second Line Department of Medical Oncology Prof. Ashraf Zeidan Abdalla Ahmed 2024
38 Diagnostic efficacy of Ovarian-Adnexal Reporting and Data System (ORADS) in Evaluation of Ovarian Lesions Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2024
39 TheUseofTraditional and Complementary Medicine by Children with Cancer in Jordan Department of Pediatric Oncology Ahmed Abdelwahab Faraag Mohammed 2024
40 High Dose Methotrexate Induced Toxicity in Children with Hematological Malignancy: Incidence and Relation to MTX Level Department of Pediatric Oncology norhan hassan mahmoud 2024